February 2, 2022 | Targeted Therapies in Oncology

It’s Time for Smarter Electronic Medical Records

February 21, 2022

Clinical Articles

Today’s electronic medical records allow providers to have accurate, up-to-date, and complete information, provide quicker access than a physical file, improve security and privacy, improve patient communication, enable safer prescriptions, and even cut costs

Immunotherapy Shakes Up Cervical Cancer Treatment Paradigm

February 17, 2022

Clinical Articles

In an interview with Lt Col Yovanni Casablanca, MD, discussed the incorporation of new treatments into the cervical cancer paradigm and provided insight into the necessity of inclusive research with novel therapies.

Triplet Achieves High Disease Control in R/M SCCHN

February 15, 2022

Clinical Articles

Findings from the phase 1/2 IPH2201-203 trial support the statement that monalizumab, cetuximab, and durvalumab show promising activity in patients with recurrent squamous cell carcinoma of the head and neck.

Differentiating Pseudoprogression From Hyperprogression in Patients Treated With Immunotherapies

February 14, 2022

Clinical Articles

Advances in the field have also led to the recognition of other clinical challenges, including unforeseen observations and complications associated with choosing the sequencing of appropriate therapeutic interventions as well as the management of drug-related complications.